pI: 4.928 |
Length (AA): 409 |
MW (Da): 45514 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There is 1 model calculated for this protein. More info on
this model, including the
model itself is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
5 | 406 | 4hcx (A) | 5 | 406 | 99.99 | 0 | 1 | 2.19799 | -1.24 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | Dormant phase. | hasan |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | Dormant phase. | murphy |
hasan | Prioritizing genomic drug targets in pathogens: application to Mycobacterium tuberculosis. |
murphy | Identification of gene targets against dormant phase Mycobacterium tuberculosis infections. |
Ortholog group members (OG5_127057)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G54340 | isocitrate dehydrogenase |
Arabidopsis thaliana | AT1G65930 | NADP+-dependent isocitrate dehydrogenase |
Arabidopsis thaliana | AT5G14590 | isocitrate dehydrogenase |
Babesia bovis | BBOV_III007260 | isocitrate dehydrogenase, NADP-dependent family protein |
Brugia malayi | Bm1_48940 | isocitrate dehydrogenase |
Brugia malayi | Bm1_48935 | Isocitrate dehydrogenase |
Candida albicans | CaO19.5211 | Mitochondrial NADP-specific isocitrate dehydrogenase |
Candida albicans | CaO19.3733 | cytosolic NADP-specific isocitrate dehydrogenase. |
Candida albicans | CaO19.11218 | N terminus of cytosolic NADP-specific isocitrate dehydrogenase. |
Candida albicans | CaO19.11217 | C terminus of cytosolic NADP-specific isocitrate dehydrogenase. |
Candida albicans | CaO19.12678 | Mitochondrial NADP-specific isocitrate dehydrogenase |
Caenorhabditis elegans | CELE_C34F6.8 | Protein IDH-2 |
Caenorhabditis elegans | CELE_F59B8.2 | Protein IDH-1, isoform C |
Dictyostelium discoideum | DDB_G0272208 | isocitrate dehydrogenase (NADP+) |
Dictyostelium discoideum | DDB_G0272210 | isocitrate dehydrogenase (NADP+) |
Drosophila melanogaster | Dmel_CG7176 | Isocitrate dehydrogenase |
Echinococcus granulosus | EgrG_001068500 | NADP dependent isocitrate dehydrogenase |
Echinococcus multilocularis | EmuJ_000016700 | isocitrate dehydrogenase 2 (NADP+) |
Echinococcus multilocularis | EmuJ_000289300 | NADP dependent isocitrate dehydrogenase |
Echinococcus multilocularis | EmuJ_001068200 | NADP dependent isocitrate dehydrogenase |
Echinococcus multilocularis | EmuJ_001068500 | NADP dependent isocitrate dehydrogenase |
Echinococcus multilocularis | EmuJ_000288600 | isocitrate dehydrogenase |
Homo sapiens | 3418 | isocitrate dehydrogenase 2 (NADP+), mitochondrial |
Homo sapiens | ENSG00000138413 | isocitrate dehydrogenase 1 (NADP+), soluble |
Leishmania braziliensis | LbrM.10.0310 | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative |
Leishmania donovani | LdBPK_100310.1 | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative |
Leishmania infantum | LinJ.10.0310 | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative |
Leishmania major | LmjF.10.0290 | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative |
Leishmania mexicana | LmxM.10.0290 | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative |
Loa Loa (eye worm) | LOAG_10665 | isocitrate dehydrogenase |
Mus musculus | ENSMUSG00000025950 | isocitrate dehydrogenase 1 (NADP+), soluble |
Mus musculus | ENSMUSG00000030541 | isocitrate dehydrogenase 2 (NADP+), mitochondrial |
Mycobacterium tuberculosis | Rv3339c | Probable isocitrate dehydrogenase [NADP] Icd1 (oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) |
Neospora caninum | NCLIV_039280 | Isocitrate dehydrogenase-like protein, related |
Neospora caninum | NCLIV_056480 | hypothetical protein |
Oryza sativa | 4339674 | Os05g0573200 |
Oryza sativa | 4336353 | Os04g0508200 |
Oryza sativa | 4324176 | Os01g0654500 |
Oryza sativa | 4327213 | Os01g0248400 |
Plasmodium berghei | PBANKA_1358600 | isocitrate dehydrogenase [NADP], mitochondrial, putative |
Plasmodium falciparum | PF3D7_1345700 | isocitrate dehydrogenase [NADP], mitochondrial |
Plasmodium knowlesi | PKNH_1255600 | isocitrate dehydrogenase [NADP], mitochondrial, putative |
Plasmodium vivax | PVX_083185 | isocitrate dehydrogenase [NADP], mitochondrial, putative |
Plasmodium yoelii | PY00592 | isocitrate dehydrogenase, NADP-dependent |
Plasmodium yoelii | PY02505 | isocitrate dehydrogenase, NADP-dependent, putative |
Saccharomyces cerevisiae | YLR174W | isocitrate dehydrogenase (NADP(+)) IDP2 |
Saccharomyces cerevisiae | YDL066W | isocitrate dehydrogenase (NADP(+)) IDP1 |
Saccharomyces cerevisiae | YNL009W | isocitrate dehydrogenase (NADP(+)) IDP3 |
Schistosoma japonicum | Sjp_0084670 | ko:K00031 isocitrate dehydrogenase [EC1.1.1.42], putative |
Schistosoma mansoni | Smp_163050 | NADP-specific isocitrate dehydrogenase |
Schmidtea mediterranea | mk4.008676.00 | |
Schmidtea mediterranea | mk4.003431.11 | |
Schmidtea mediterranea | mk4.003451.03 | Isocitrate dehydrogenase |
Trypanosoma brucei gambiense | Tbg972.11.950 | isocitrate dehydrogenase, putative |
Trypanosoma brucei gambiense | Tbg972.8.3420 | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative |
Trypanosoma brucei | Tb927.8.3690 | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative |
Trypanosoma brucei | Tb927.11.900 | isocitrate dehydrogenase, putative |
Trypanosoma congolense | TcIL3000_0_43620 | isocitrate dehydrogenase, putative |
Trypanosoma congolense | TcIL3000_0_50590 | isocitrate dehydrogenase, putative |
Trypanosoma cruzi | TcCLB.511575.60 | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative |
Trypanosoma cruzi | TcCLB.506925.319 | isocitrate dehydrogenase, putative |
Toxoplasma gondii | TGME49_266760 | isocitrate dehydrogenase |
Toxoplasma gondii | TGME49_313140 | isocitrate dehydrogenase |
Theileria parva | TP04_0620 | isocitrate dehydrogenase (NADP+), putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
mtu3399 this record | Mycobacterium tuberculosis | non-essential | nmpdr |
Tb11.03.0230 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.03.0230 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.03.0230 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb11.03.0230 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
Tb927.8.3690 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.8.3690 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.8.3690 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.8.3690 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
PBANKA_1358600 | Plasmodium berghei | Slow | plasmo |
TGME49_313140 | Toxoplasma gondii | Probably non-essential | sidik |
TGME49_266760 | Toxoplasma gondii | Probably non-essential | sidik |
TGME49_313140 | Toxoplasma gondii | Probably essential | sidik |
TGME49_266760 | Toxoplasma gondii | Probably essential | sidik |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | isocitrate dehydrogenase 1 (NADP+), soluble | Compounds | References |
Target | Type | Source | Notes |
---|---|---|---|
Rv3339c | purified protein | BRENDA | A protein with this EC number or name or sequence has been purified from Mycobacterium phlei ( 1 ) |